Title |
The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy
|
---|---|
Published in |
World Journal of Biological Psychiatry, July 2009
|
DOI | 10.1080/15622970500213871 |
Pubmed ID | |
Authors |
Thomas C. Baghai, Alain Marcuse, Melanie Brosch, Cornelius Schüle, Daniela Eser, Caroline Nothdurfter, Yvonne Steng, Ines Noack, Katrin Pietschmann, Hans-Jürgen Möller, Rainer Rupprecht |
Abstract |
A major problem in the treatment of severe depression is the onset latency until clinical improvement. So far, electroconvulsive therapy (ECT) is the most effective somatic treatment of depression. This holds especially true for treatment-refractory disturbances. However, not all patients respond to conventional unilateral ECT. In certain cases, subsequent clinical response can be achieved using bilateral or high-dose unilateral ECT. Also, a concomitant pharmacotherapy can be utilized to augment therapeutic effectiveness. Surprisingly, data in this field are widely lacking and only few studies showed advantages of an ECT/tricyclic antidepressant combination. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 6% |
Ireland | 1 | 3% |
India | 1 | 3% |
Unknown | 30 | 88% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 12% |
Researcher | 3 | 9% |
Student > Doctoral Student | 3 | 9% |
Student > Bachelor | 3 | 9% |
Student > Master | 3 | 9% |
Other | 6 | 18% |
Unknown | 12 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 38% |
Neuroscience | 4 | 12% |
Agricultural and Biological Sciences | 1 | 3% |
Computer Science | 1 | 3% |
Psychology | 1 | 3% |
Other | 3 | 9% |
Unknown | 11 | 32% |